Infectious complications following left ventricular assist device
implantation can carry significant morbidity and mortality. The main
tenet of treatment is source control which entails local wound care,
intravenous antimicrobial therapy, surgical debridement, and at times,
soft tissue flap coverage. The mode of therapy depends on the severity,
etiology, and location of infection as well as the clinical status of
the patient. We describe a case of a 46 year old male who underwent left
ventricular assist device placement complicated by pump thrombosis,
recurrent infection, and hardware exposure who was successfully treated
with a novel method of staged, soft tissue reconstruction.